Carregant...
Rebasing the Medicare Payment for Dialysis: Rationale, Challenges, and Opportunities
After Medicare’s implementation of the bundled payment for dialysis in 2011, there has been a predictable decrease in the use of intravenous drugs included in the bundle. The change in use of erythropoiesis-stimulating agents, which decreased by 37% between 2007, when its allowance in the bundle was...
Guardat en:
| Publicat a: | Clin J Am Soc Nephrol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Nephrology
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4255403/ https://ncbi.nlm.nih.gov/pubmed/25189926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.03830414 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|